Showing results (31-40 of 159) with videos related to
Sort By:
Pageof 16
Bulletin Du Cancer|June 7, 2024
[Incidence, characteristics and survival of patients with pneumocystis pneumonia in solid oncology]Alexandre Peinoit, Léa Muzellec, Estelle Neveu, et al.Cancers|September 9, 2023
Locoregional Treatment in Intrahepatic Cholangiocarcinoma: Which Treatment for Which Patient?Héloïse Bourien, Chiara Carlotta Pircher, Boris Guiu, et al.Cancer|June 30, 2011
Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinomaJulien Edeline, Eveline Boucher, Yan Rolland, et al.European Journal of Radiology|July 18, 2016
Comparison of Choi criteria and Response Evaluation Criteria in Solid Tumors (RECIST) for intrahepatic cholangiocarcinoma treated with glass-microspheres Yttrium-90 selective internal radiation therapy (SIRT)Luc Beuzit, Julien Edeline, Vanessa Brun, et al.Cancers|April 12, 2022
Targeted Therapies for Perihilar CholangiocarcinomaSimon Gray, Angela Lamarca, Julien Edeline, et al.JMIR Research Protocols|August 17, 2018
Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled TrialNikhil Chauhan, Janet Bukovcan, Eveline Boucher, et al.Cancer Treatment Reviews|January 28, 2020
Current standards and future perspectives in adjuvant treatment for biliary tract cancersAngela Lamarca, Julien Edeline, Mairéad G McNamara, et al.Melanoma Research|April 27, 2021
Prognostic impact of thyroid dysfunctions on progression-free survival in patients with metastatic melanoma treated with anti-PD-1 antibodiesAlexandra Frelau, Eva Jali, Boris Campillo-Gimenez, et al.Targeted Oncology|February 6, 2023
Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French PerspectiveCindy Neuzillet, Pascal Artru, Eric Assenat, et al.Pageof 16